Paul John Galardy MD
Pediatric Hematology/Oncology/Bone Marrow Transplant, Mayo Clinic
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Galardy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 1997 - 2001- Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 1997 - 2000
Boston University School of MedicineClass of 1997
Certifications & Licensure
MN State Medical License 2006 - 2027
MA State Medical License 2000 - 2007
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2014, 2016-2017
Publications & Presentations
PubMed
- Comparative Analysis of Familial Versus Infectious Neonatal Hemophagocytic Lymphohistiocytosis.Jacob R Greenmyer, Megan L Anderson, Charles S Cameron, Lincoln A Kranz, Wyatt S Hahn
Journal of Pediatric Hematology/oncology. 2026-04-01 - Severe hypertriglyceridemia associated with calaspargase pegol.Alexis K Kuhn, Madeleine O'Keefe, Mira Kohorst, Jessica Kalmes, Paul Galardy
Leukemia & Lymphoma. 2025-12-01 - Prolonged Therapeutic Serum Asparaginase Activity Levels After Administration of Calaspargase Pegol.Catherine E Martin, Madeleine B O'Keefe, Taylor Gullickson, Mira A Kohorst, Anand Srinivasan
Pediatric Blood & Cancer. 2025-12-01
Journal Articles
- UCH-L1 Bypasses mTOR to Promote Protein Biosynthesis and Is Required for MYC Driven Lymphomagenesis in MicePaul Galardy, MD, Blood
Press Mentions
Researchers Have Found a Way to Treat Cancer by Using Living Cells, Synthetic BiologyFebruary 21st, 2021
Head to the Lab for the Treatments of TomorrowFebruary 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
